Delivery Order SPE2DB22D2007-SPE2DB24FJ6JV

Award Date 9/24/24
Potential Completion Date 10/16/24
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $44,037.00 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,314,602 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. The IDC enables DLA to efficiently...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,539,303 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has a completion date of February 26, 2024, and a potential value of $1,048.48. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a $3,145.44 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Xeomin 100 unit vials. The order has an ultimate completion date of October 1, 2024 and was awarded on September 10, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The IDC enables the DLA to...
This is a $43,088.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,558,050 units of XEOMIN 200 unit vials, a specialized pharmaceutical product. The order has a firm fixed price and no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,621.20 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide 4,563,910,634 units of XEOMIN 100 unit vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
This is a $1,117.48 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 100 unit vials, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $40,004.40 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of XEOMIN 100 unit vials. The contract has an ultimate completion date of October 8, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide essential medical commodities to support military treatment facilities and federal healthcare programs. The company holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $93,868.32, is for the delivery of 4,568,082,632 vials of the medication XEOMIN 200 UNIT. The contract has an ultimate completion date of May 20, 2025 and was awarded on April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $5,587.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XEOMIN 100 unit vials and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The contract has a firm fixed price of $11,174.80 and a performance period through May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6JV
    Delivery Order

This is a $44,037 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 200-unit vials of the pharmaceutical product XEOMIN. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation and is scheduled for completion by October 16, 2024.

Generated 12/24/24, 9:22 AM